Colorado’s Prescription Drug Affordability Board (PDAB), established under Senate Bill 21-175 and updated under House Bill 23-1225, is a Type-1 Board within the Division of Insurance that has the authority to review prescription drug costs and evaluate their impact on Coloradans through affordability reviews of prescription drugs. The Board may then recommend ways to address those costs and may set an upper payment limit for certain prescription drugs.
To receive PDAB and PDAAC updates directly in your inbox, click here. To subscribe, you will need to enter your email and then choose Updates From Divisions > Division of Insurance > Division of Insurance Prescription Drug Affordability Board.
The next PDAB meeting will be held on Friday, July 11, 2025 from 10 am - 1 pm MT.
Register for July 11 PDAB Meeting
The next PDAAC meeting will be held on Thursday, August 28 2025 from 9 - 11 am MT.
Register for August 28 PDAAC Meeting
PDAAC is currently recruiting new council members to represent Labor unions and Carriers. If you are interested in serving a 3-year term on the PDAAC, please fill out the linked application.
Office hours are an informal space for stakeholders to ask questions about PDAB processes and to provide resources for stakeholders to testify during rulemaking hearings. Office hours are currently on hold.
The UPL rulemaking for Enbrel began during the May 23 PDAB meeting. The second Enbrel UPL rulemaking hearing will be on July 11. The Board anticipates holding at least 3 rulemaking hearings for each drug. For more information on PDAB rulemaking and how to provide testimony during a PDAB rulemaking hearing, please visit the linked PDAB Rulemaking Guide.
Providing Public Comment
The PDAB welcomes general public comments during PDAB meetings. Comments are limited to 2 minutes per person. Public comment is not a time for the Board to interact with the public.
Providing Testimony
Verbal or written testimony occurs only during PDAB rulemaking hearings and will be included in the rulemaking record. The Board may ask questions of stakeholders during their testimony. Visit the PDAB Rulemaking Guide for more information on testifying at a PDAB rulemaking hearing.